Navigation Links
Skin Lesion Identification System to Auction on November 11th at ICAP Ocean Tomo's Fall 2010 Live IP Auction

CHICAGO, Sept. 14 /PRNewswire/ -- ICAP Ocean Tomo, the intellectual property brokerage division of ICAP plc (IAP.L) and the world's premier patent auction firm, will auction technology related to skin lesion detection and classification at the upcoming Fall 2010 Live Auction in Napa, California on November 11th.



In the US, nearly 2.5 million patients are treated each year for skin lesions such as pressure ulcers, and approximately 60,000 patients die from related complications.(1) Traditional treatment includes regular monitoring of the skin lesion by medical professionals, however, this technique has several disadvantages such as human error and the high cost of labor required to administer treatment. The assets of this lot disclose a system that provides for highly efficient, accurate, and cost effective monitoring of skin lesions. Comprised of a camera, processor, and reporting device, the system identifies and classifies skin lesions as well as evaluates the effectiveness of the treatment.  The camera in the system captures a two-dimensional image of the skin lesion which is then sent to the processor and converted into a three-dimensional image. The converted image can be compared to previously stored images to track the effectiveness of treatment. As the system relies on electronic comparisons, it generates highly accurate results. In addition, the electronic nature of the stored data provides for easy storage and transfer to remote locations for reporting.

"Lesions can be treated by several methods with varying degrees of effectiveness in different patients. It is important to determine the most suitable treatment for each patient as fast as possible because in addition to reducing patient's suffering, in case of pressure ulcers, care providers suffer regulatory financial consequences and bad reputation related to lesion's frequency and duration," said co-inventor Dr. Josef Osterweil. "The accuracy of our system, with or without mining, allows the user to detect the smallest changes of the lesion thus allowing rapid adjustment of treatment."

The cost of treatment for skin lesions such as pressure ulcers in the US is estimated to be $11 billion per year.(2) "This lot should be of interest to medical device manufacturers, health care service providers, insurance companies, and other entities operating in the healthcare field," said Dean Becker, ICAP Ocean Tomo CEO.

Experimental equipment and data is available upon request. To learn more about this lot and how to participate in the Fall Live Auction please contact Dean Becker at

To view the full Fall Auction Catalog visit

1 & 2

About ICAP Ocean Tomo LLC

ICAP Ocean Tomo is the intellectual property brokerage division of ICAP and the world's premier patent auction firm.

About ICAP

ICAP is the world's premier interdealer broker and provider of post trade services. The Group matches buyers and sellers in the wholesale markets in interest rates, credit, commodities, foreign exchange, emerging markets, equities and equity derivatives through voice and electronic networks. ICAP is also the source of global market information and research for professionals in the international financial markets. ICAP plc was added to the FTSE 100 Index on 30 June 2006. For more information go to

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
2. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
3. Stenting Techniques Vie in Branchpoint Lesions
4. TARGETED GENE DELIVERY SIGNALS CANCER VACCINATION IN VIVO: Intravenous Infusions of Rexin-G Followed by Reximmune-C Induce Tumor Necrosis and Recruitment of Tumor Infiltrating Lymphocytes in Cancerous Lesions (ASCO 2008)
5. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
6. 12-Month ATLANTA Trial Data Show Sustained Benefit of Catania(TM) Stent in Treatment of De Novo Coronary Lesions
7. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
8. Breast-Specific Gamma Imaging Identifies Occult Lesions Using Multi-Modality Imaging for Biopsy
9. Genomic Health Announces Identification of Genes Associated With Colon Cancer Recurrence Across Multiple Studies
10. FDA Grants Market Clearance for the LipiScan(TM) Coronary Imaging System Developed by InfraReDx, Inc. - A Novel Spectroscopy System for the Identification of Lipid Core Containing Plaques of Interest in the Coronary Arteries
11. New stem cell identification technology could cure breast cancer
Post Your Comments:
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):